Last edition
News about "Marc Kikuchi"
Glenmark Pharmaceuticals to Launch Micafungin for Injection in US in September 2025
Glenmark Pharmaceuticals Inc., USA has announced the September 2025 launch of Micafungin for Injection USP, 50 mg and 100 mg vials, the bioequivalent of Astellas Pharma’s Mycamine.
Marc Kikuchi | 19/08/2025 | By Mrinmoy Dey | 131
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members